Neurosciences articles for United States of America (USA)

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 758

Article ‘Count’ for Neurosciences.

Journal Count Share
3 0.20
An Autophagy-Sensitive Nanoplatform via Chirality-Selective Modulation for Functional Peripheral Nerve Repair and Target Organ Homeostasis 0.06
Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles 0.03
Triple-Cue-Guided Multichannel Hydrogel Conduit to Synergistically Enhance Peripheral Nerve Repair 0.11
5 4.83
Subarachnoid Trabeculae Suppress Cerebrospinal Fluid Pressurization During Translational Impact Loading using Instrumented Biomimetic Head Surrogates 1.00
Peptide Concentration Gradients and Aligned Microfiber Topography Synergize to Speed and Direct Schwann Cell Migration 1.00
Lipid nanoparticle-mediated Cd14 siRNA delivery ameliorates the acute inflammatory response to intracortical microelectrode implantation 1.00
Microstructural damage progression in the pia-arachnoid complex 1.00
Repeated loading and damage progression in cerebral arteries 0.83
1 1.00
Elastomeric Micro-Balloons for Remote Control of Cerebral Blood Flow and Real-Time In vivo Imaging of Rodent Brain Response to Hypoperfusion 1.00
1 1.00
Racial Disparities in Incident and Recurrent Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis 1.00
1 0.42
Landscapes of missense variant impact for human superoxide dismutase 1 0.42
1 1.00
Can Maternal Metformin Protect the Developing Fetal Brain? 1.00
3 3.00
Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson’s Disease 1.00
Parenchymal and Dyshoric Fibrillar Amyloid Pathology in the rTg-D Rat Model of Cerebral Amyloid Angiopathy Type-2 1.00
Novel Kinesin Family 1A Variants Linked to Atypical Parkinsonism Elicit Altered Neuronal TDP-43 Interactions and Dendritic Atrophy 1.00
2 1.09
Systematic and Quantitative Investigation of Newly Synthesized Proteins Reveals Distinct Ion Homeostasis and Mitochondrial Changes between Cuproptosis and Ferroptosis in Human Cells 1.00
Near-Infrared Chemiluminescence Probe for Superoxide Anion Imaging in Alzheimer’s Disease 0.09
2 0.14
General anesthesia and systemic hyperosmolality modulate lumbar intrathecal drug distribution in female rats. 0.04
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects. 0.09
2 2.00
Early Intensive Blood Pressure Reduction After Intracerebral Hemorrhage Is Associated With Worse Functional Outcome: The Risk of Overshooting Blood Pressure Goals 1.00
Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase L1 for Acute Traumatic Intracranial Lesions: The PIONEER Diagnostic Accuracy Study 1.00
1 0.72
Action Collaborative on Traumatic Brain Injury Care: Adapted Clinical Practice Guideline 0.72
69 50.25
Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy 0.06
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion 0.08
Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease 0.19
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis 0.01
Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease 1.00
Cerebrospinal Fluid from Restless Legs Syndrome Patients Reduces Iron Uptake in Blood–Brain Barrier Endothelial Cells by Disrupting the Regulation of Transferrin Receptors 1.00
Supratentorial Brain Lesions in Unconscious Patients Map to a Common Human Brain Circuit 0.89
Network Colocalization Correlates of Depression and Anxiety in Pediatric Focal Cortical Dysplasia‐Related Epilepsy 1.00
Effects of Blood Pressure Lowering Across Hematoma Volume in Acute Intracerebral Hemorrhage: Pooled Analysis of the Four INTERACT and ATACH-2 Trials 0.04
Population‐Based Epidemiology of Autoimmune Seizures and Epilepsies 0.98
Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers 1.00
Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism 0.89
Distinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry-Based Study 0.29
CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery 0.02
The Clinical Spectrum and Neurodevelopmental Pathogenesis of KPTN-Related Disorder in a Mouse Model 0.57
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment 0.92
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.55
Individualized Treatment in Distal and Medium Vessel Occlusion Stroke Using a Validated Explainable Counterfactual Treatment Estimation Model 0.67
Severe, Non‐apneic Respiratory Dysfunction and Hypoxia following Generalized Convulsive Seizures 0.95
Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths 0.97
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale 0.63
Novel Aggressive Subtype of Multiple System Atrophy Identified by Unsupervised Machine Learning 0.93
Reframing the Risks of Deep Brain Stimulation: A Comparison of 2.8 Million Elective Surgeries From the NSQIP Database 1.00
Using Expert‐Cited Features to Detect Leg Dystonia in Cerebral Palsy 1.00
Clot Composition Profiling in Large Vessel Occlusion Stroke Via Radiomics 1.00
Probabilistic Lesion Mapping to Optimize Thalamotomy Targets for Focal Hand Dystonia 0.50
A Patient‐Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis 1.00
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.49
Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease 0.94
Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral Hemorrhage 0.94
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.28
<atl>Anatomical Progression of Neuropathology in scpFTLD/scp ‐ scpTDP/scp Type C and Linkage to Annexin scpA11/scp</atl> 1.00
Tenecteplase Versus Alteplase for First‐Pass Reperfusion in Basilar Artery Occlusion Stroke Thrombectomy 1.00
Additive Effects of White Matter Hyperintensity and APOE ε4 Status on Risk of Incident Dementia in Two Large Longitudinal Cohorts 0.94
Thalamic Stimulation Induced Changes in Network Connectivity and Excitability in Epilepsy 0.95
Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain Injury 1.00
Real‐World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease‐Modifying Therapy in Pediatric Multiple Sclerosis 0.96
<atl>Sensorimotor Cortex High Frequency Oscillations Characterize Motor Symptom Severity during scpDeep Brain Stimulation/scp Surgery for Parkinson's Disease</atl> 1.00
Disruption of the Blood–Brain Barrier Predicts Progression of Cerebral Small Vessel Disease White Matter Hyperintensities 1.00
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.23
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis 0.64
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study 0.47
Resilience to Endoplasmic Reticulum Stress Mitigates Membrane Hyperexcitability Underlying Late Disease Onset in a Murine Model of scpSCA6/scp 1.00
scpMarkVCID2/scp Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics 0.95
Behavior Decoding Delineates Seizure Microfeatures and Associated Sudden Death Risks in Mouse Models of Epilepsy 1.00
A Distinct Immunological Signature in Late‐Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study 0.95
iHCN2/i‐Associated Neurodevelopmental Disorders: Data from Patients and iXenopus/i Cell Models 0.19
Uncovering Image‐Driven Subtypes with Distinct Pathology and Clinical Course in Autopsy‐Confirmed Four Repeat Tauopathies 1.00
Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis 0.86
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study 0.25
Clinical and Cognitive Profiles of Individuals with Alzheimer's Disease and Comorbid Seizures 1.00
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.72
Brain Endothelial Soluble scpST2/scp Production and Cerebral Edema in a Rat Model of Ischemic Stroke 0.89
Behavior‐scpiEEG/scp‐Spectral‐Power‐Correlation: Defining Neural Substrates of Naturalistic Behavior 1.00
Adjunctive scpThrombolytics/scp After Successful Endovascular Reperfusion: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials 0.29
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1‐Linked Amyotrophic Lateral Sclerosis 0.03
Toward a Universal Map of EEG: A Semantic, Low‐Dimensional Manifold for scpEEG/scp Classification, Clustering, and Prognostication 0.50
Regional and Global Changes in Brain Structure 1‐Year Post Pediatric “Mild” Traumatic Brain Injury 0.97
Frequency of Microvascular Pathology and Hippocampal Atrophy on scpMagnetic Resonance Imaging/scp in a Community Study of Alzheimer's Disease with Blood‐Based Biomarkers 1.00
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline 0.50
Chronic Striatal Cholinergic Interneuron Excitation Causes Cerebral Palsy‐Related Dystonic Behavior in Mice 1.00
μ‐Opioid Receptor Dynamics in the Parameningeal Tissue During Migraine Attacks 0.93
The Role of Electroencephalography in Predicting Post-Stroke Seizures and an Updated Prognostic Model (SeLECT-EEG) 0.19
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis 0.86
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia 1.00
Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes 0.22
The Relationship between Rest Tremor and Underlying Lewy Pathology in Essential Tremor: A Clinical‐Pathological Study of 201 Cases 1.00
Blood α‐Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies 1.00
Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort 1.00
2 0.15
Efgartigimod in Sjögren’s disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO) 0.13
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.03
13 12.53
Utilization and Cost of VA Outpatient Clinics for Service Members and Veterans Treated in VA Polytrauma Rehabilitation Centers for Traumatic Brain Injury: A VA TBI Model Systems Study 1.00
Gaps in Access to Cognitive Rehabilitation Referrals Among Veterans with Mild Traumatic Brain Injury 1.00
A Non-Inferiority Randomized Clinical Trial Comparing Three Delivery Formats of a Rehabilitation Intervention to Reduce Fatigue among People with Multiple Sclerosis 0.73
Activity Measure for Post-Acute Care, Computer Adapted Test versus “6-Clicks”; do they agree in individuals post-ischemic acute stroke? 1.00
A Novel Examination of the Impact of Time and Reliability on Minimal Detectable Differences Using the Coma Recovery Scale – Revised 1.00
Differences in narrative discourse ability in traumatic brain injury and a neurotypical comparison group: Influence of age, education, and sex 1.00
Echoes of the Battlefield: Five-Year Longitudinal Cognitive Trajectories Show Trend of Recovery for Deployment-Related Mild TBI in the LIMBIC-CENC Cohort 1.00
New Diagnostic Criteria for Mild Traumatic Brain Injury: Medical-Legal Considerations 0.80
Predicting Suicidality in Veterans/Service members over 5 Years after TBI: A VA Model Systems Study 1.00
Primary Care and Brain Injury Physician Utilization for Persons Living with Chronic Brain Injury 1.00
A Three-Point Perspective on Post-Stroke Fatigue: A Grounded Theory Study 1.00
A Qualitative Examination of Chronic Care Needs of People with Traumatic Brain Injury 1.00
Moderating Effects of Clinical and Social Factors on Fatigue Improvement after an Online Peer-led Fatigue Self-management Intervention in People with Systemic Sclerosis: A Secondary Analysis of a Randomized Controlled Trial 1.00
3 2.26
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study 0.50
Visual hypersensitivity as a transdiagnostic marker of surgical pain response in arthritis and chronic pain syndromes 0.88
Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines 0.89
41 25.04
Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression 0.77
The deep brain stimulation response network in Parkinson’s disease operates in the high beta band 0.38
Cerebral amyloid angiopathy and Alzheimer's and related pathologies across APOE genotypes 1.00
Clinical-biological Alzheimer’s disease stage concordance: insights from cohorts and autopsy data 0.19
Elucidating the nociceptive role of CGRP in migraine headache 1.00
Neuronal titration of Snca via enhancer disruption mitigates disease onset in a Parkinson's disease mouse model 1.00
Somatic gene mutations in the motor cortex of patients with sporadic amyotrophic lateral sclerosis 0.13
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study 0.02
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia 0.88
Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome 1.00
Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination 0.08
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 0.30
Atrophy progression in frontotemporal lobar degeneration-TDP-C with primary progressive aphasia 1.00
Transcriptome of the human C2 dorsal root ganglia in C1-2 arthrodesis surgery: insight for neck pain 0.97
Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil 0.96
Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophy 0.35
Right hemisphere language network plasticity in aphasia 1.00
Genotype-specific interferon signatures in amyotrophic lateral sclerosis relate to disease severity 0.23
Aberrant striatal firing mediates impulsive decision-making in a mouse model of Parkinson’s disease 1.00
Brain signatures of nociplastic pain: Fibromyalgia Index and descending modulation at population level 0.09
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.15
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.28
Leveraging machine learning to predict Parkinson's disease using pre-symptomatic proteomics data 1.00
Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache 0.60
Phenotypic clustering in tuberous sclerosis complex reveals four distinct disease trajectories 1.00
Structural network-specific effect of extreme capsule stimulation for drug-resistant focal epilepsy 0.05
Traumatic brain injury or head impacts from contact sports are associated with tau astrogliopathy 0.80
Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy 0.84
Comparative effectiveness of anti-seizure medications in emulated trials using medical informatics 1.00
Occludin modulates HIV and ischaemic stroke response via mitochondrial antiviral signalling pathway 1.00
Brain atrophy patterns in anti-IgLON5 disease 0.14
Common neuropathologic change drivers of hippocampal sclerosis of ageing 1.00
Artificial intelligence models using F-wave responses predict amyotrophic lateral sclerosis 1.00
The association of seizure control with neuropathology in dementia 1.00
Spreading depolarization triggers pro- and anti-inflammatory signalling: a potential link to headache 0.06
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis 0.13
A digital motor score for sensitive detection of progression in Huntington’s disease 0.09
Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of iPMP22/i variants 0.69
Redefining diagnostic lesional status in temporal lobe epilepsy with artificial intelligence 0.86
CSF proteomics of semorinemab Alzheimer’s disease trials identifies cell-type specific signatures 0.92
Oxygen extraction fraction in small vessel disease: relationship to disease burden and progression 0.06
3 2.85
Spatial Cross-talk Modeling of the Tumor Microenvironment Identifies CCR5-Mediated Glia-to-Glia Signaling as a Key Regulator of Brain Metastatic Progression 1.00
C5aR1 inhibition alleviates cranial radiation-induced cognitive decline. 0.85
Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity 1.00
11 10.01
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorder 0.70
The effect of shingles vaccination at different stages of the dementia disease course 0.57
IL-1R1-positive dorsal raphe neurons drive self-imposed social withdrawal in sickness 0.93
A brain center that controls consummatory responses 1.00
Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling 0.92
Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS 1.00
Mast cells regulate the brain-dura interface and CSF dynamics 1.00
Cell-type-directed network-correcting combination therapy for Alzheimer’s disease 1.00
In vivo prime editing rescues alternating hemiplegia of childhood in mice 0.89
Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications 1.00
The structure of human sweetness 1.00
1 1.00
Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson’s disease 1.00
1 0.85
Endoplasmic reticulum Nogo drives AgRP neuronal activation and feeding behavior 0.85
2 1.25
Transcriptional code for circuit integration in the injured brain by transplanted human neurons 0.25
An organ-chip model of sporadic ALS using iPSC-derived spinal cord motor neurons and an integrated blood-brain-like barrier 1.00
3 1.35
Herpes Simplex Virus Type 1 Encephalitis: A Prospective Population-Based Cohort Study 0.10
Cerebral Malaria and Severe Malarial Anemia, but not Other Forms of Severe Malaria, Are Associated With Long-Term Cognitive Impairment 0.57
Electroencephalogram Features Distinguish Cases of Cerebral Malaria Among Malawian Children With Fever and Coma 0.68
3 2.67
Results of the Pediatric Guideline Adherence and Outcomes (PEGASUS) Program Versus Usual Care Pragmatic Randomized Controlled Trial in Severe Traumatic Brain Injury. 0.67
Unique Pattern of Coagulopathy Among Patients With Severe Traumatic Brain Injury: A Principal Component Analysis of Hemorrhagic Shock Trials. 1.00
Early Relative Hypotension Below Noninvasive Cerebral Oximetry-Derived Optimal Blood Pressure Thresholds in Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. 1.00
2 2.00
Synaptic-like coupling of macrophages to myofibers regulates muscle repair 1.00
Distinct neural representations of hunger and thirst in neonatal mice before the emergence of food- and water-seeking behaviors 1.00
1 0.12
The p75 neurotrophin receptor controls the skeletal stem cell niche through sensory innervation 0.12
1 1.00
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. 1.00
1 0.08
Exposure to low-dose ionizing radiation and dementia mortality in Canadian nuclear power plant workers 0.08
1 1.00
Acrolein-Induced Alterations in Morphology and Stress Resilience in hiPSC-Derived Cortical Neurons 1.00
2 0.20
Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial 0.03
SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias 0.17
1 0.91
Single-nucleus multiomic profiling of the aging mouse substantia nigra reveals conserved gene alterations linked to Parkinson's disease 0.91
6 4.52
State-specific enhancer landscapes govern microglial plasticity 0.94
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis 0.51
Rod-shaped microglia interact with neuronal dendrites to attenuate cortical excitability during TDP-43-related neurodegeneration 1.00
Excitatory-neuron-derived interleukin-34 supports cortical developmental microglia function 1.00
Optogenetic vagal nerve stimulation attenuates heart failure by limiting the generation f monocyte-derived inflammatory CCRL2+ macrophages 0.07
Inflammasome signaling in astrocytes modulates hippocampal plasticity 1.00
2 1.02
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis 0.02
Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation 1.00
10 4.13
Long-Term Cognitive Ability and Academic Achievement After Childhood Severe Malaria 0.54
Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke 0.04
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease 1.00
Intra-Arterial Alteplase After Successful Endovascular Reperfusion in Acute Stroke 0.03
Levodopa Added to Stroke Rehabilitation 0.03
In Utero Embolization for Fetal Vein of Galen Malformation 1.00
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours 0.10
Influenza-Associated Acute Necrotizing Encephalopathy in US Children 1.00
Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy 0.05
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.34
9 8.20
Oxidative stress impairs processive motility of the axonal transport motor KIF1A 1.00
Extracellular vesicles released from blood-brain barrier endothelial cells mediate brain Iron accumulation during LPS-induced brain Inflammation 1.00
Full-Length Tau Seeded by C-Shaped Tau Fibrils is Conformationally Variable 1.00
Alzheimer’s disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II 1.00
Structural and mechanistic characterization of heparin interactions with tau fibrils 1.00
Skin-derived α-synuclein strains from PD, DLB, and MSA induce distinct intracellular pathology and neurodegeneration 1.00
Seeding biosensor cell line that reproduces the Alzheimer tau fold 0.20
Development of a robust, physiologically relevant neuronal tau aggregation assay for tau-related drug discovery 1.00
Polyserine–tau interactions modulate tau fibrillization 1.00
4 2.50
MRI Assessment of Median Nerve Size in Patients with Proximate Electrodiagnostic Studies. 0.64
Subjective and Functional Dysphagia After Anterior Cervical Spine Surgery: A Prospective Controlled Study. 0.91
Spinal Fusion in Patients with GMFCS IV or V Cerebral Palsy: Durable Correction and Lasting Quality of Life Improvements: Five-Year Multicenter Outcomes. 0.88
The Utility of a Prediction Model Using Neurological Examination Findings for Diagnosing Degenerative Cervical Myelopathy. 0.08
3 1.72
Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism 1.00
Nonmuscle myosin II regulates presynaptic actin and neuronal mechanobiology in Drosophila 0.67
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson’s disease 0.05
24 15.86
MESH1-mediated coenzyme A degradation drives ferroptosis sensitivity and muscle pathology 0.70
Pathogenic variants in BORCS5 Cause a Spectrum of Neurodevelopmental and Neurodegenerative Disorders with Lysosomal Dysfunction 0.26
Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson’s disease pathogenesis 0.10
Conserved sleep disturbances in FOXP1 syndrome originate from developmental dysregulation of peptidergic signaling 0.13
N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson’s disease models 0.85
Disruption of CSF-1 receptor-mediated metal ion homeostasis in the murine brain promotes neurodegenerative disease 0.65
Inflammasome adaptor ASC promotes sustained neuroinflammation and mild cognitive impairment in a closed-head injury model 0.13
Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice 1.00
Neutrophil-microglia interaction drives motor dysfunction in neuromyelitis optica model induced by subarachnoid AQP4-IgG 1.00
Base editing rescues seizures and sudden death in a SCN8A mutation-associated developmental epileptic encephalopathy model 1.00
Mouse model of atypical DAT deficiency syndrome uncovers dopamine dysfunction associated with parkinsonism and ADHD 0.09
Astrocyte-intrinsic signaling of chitinase-like protein CHI3L1 drives inflammation and amplifies demyelination in neuromyelitis optica 0.17
Spinal α2δ-1 induces GluA3 degradation to regulate assembly of calcium-permeable AMPA receptors and pain hypersensitivity 1.00
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy 0.02
Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variant 0.75
Aggregation shifts amyloid-β peptides from synaptogenic to synaptotoxic 1.00
Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy 1.00
The NaV1.5 auxiliary subunit FGF13 modulates channels by regulating membrane cholesterol independent of channel binding 1.00
Age-dependent brain responses to mechanical stress determine resilience in a chronic lymphatic drainage impairment model 1.00
Sensory neuron–expressed FGF13 controls nociceptive signaling in diabetic neuropathy models 0.84
4E-BP1–dependent translation in microglia controls mechanical hypersensitivity in male and female mice 0.18
Hyperinsulinemia-induced upregulation of adipocyte TPH2 contributes to peripheral serotonin production, metabolic dysfunction, and obesity 1.00
AgRP neuron hyperactivity drives hyperglycemia in a mouse model of type 2 diabetes 1.00
The gut microbiome controls reactive astrocytosis during Aβ amyloidosis via propionate-mediated regulation of IL-17 1.00
1 0.93
Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease 0.93
3 2.92
Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis 1.00
Adrenal Corticosteroids and Increased Intracranial Pressure in Nonimmunocompromised Patients With Cryptococcal Meningitis 1.00
Cerebrospinal Fluid Immune Cell Alterations in Women With Neuropsychiatric Long COVID 0.92
40 32.67
Genetically encoded constitutive upregulation of β2 subunit containing neuronal nicotinic acetylcholine receptors is neuroprotective in female parkinsonian mice 1.00
Rab27b: A Modulator of Lysosomal Function and Alpha-Synuclein Clearance in Parkinson's Disease 1.00
Voluntary Dissociation of Motor Unit Activity in the Vastii Muscles 0.17
Timbre Encoding in the Inferior Colliculus 1.00
Aberrant Cerebellar-Recipient Thalamic Activity in Two Mouse Models with Prominent Tremor or Bradykinesia 1.00
Longevity factor klotho and resistance to cognitive deficits in individuals with Parkinson’s disease and in an α-synuclein mouse model 1.00
Hemodynamic and Electrophysiological Progression of the Rose Bengal Photothrombotic Stroke Model in Mice 0.11
Alzheimer’s Pathology Enhances Excitatory Synaptic Input and Integration in VTA Dopamine Neurons 1.00
Divergent Roles of Nucleus Accumbens D1- and D2-MSNs in Regulating Hedonic Feeding 1.00
Motoneurons inhibitory synapses homeostatically respond to neuronal activity and modulate Amyotrophic Lateral Sclerosis pathogenesis 0.09
Single-Cell-Resolution Fate Mapping Reveals Embryonic Venous Origins of Fenestrated Hindbrain Choroid Plexus Vasculature 1.00
In Vivo Screen of Parkinson’s Disease GWAS Risk Genes Identifies ARIH2 as a Novel Regulator of α-Synuclein Toxicity in Dopaminergic Neurons 1.00
Alzheimer’s Disease Pathologies Affect Dopaminergic Neural Mechanisms of Memory 1.00
In Vivo Expression of an SCA27A-Linked FGF14 Mutation Results in Haploinsufficiency and Impaired Firing of Cerebellar Purkinje Neurons 1.00
The increased activity of CaV3.2 channels contributes to nociceptors’ hyperexcitability and chronic neuropathic pain following spinal cord injury in mice 1.00
Caudal Granular Insular Cortex to Somatosensory Cortex I: A critical pathway for the transition of acute to chronic pain 1.00
Non-canonical Taste Transduction of Sugars Elicits Responses in a Dedicated Subset of Gustatory Afferent Neurons 1.00
HDAC6 Inhibition Reduces Seeded Tau and α-Synuclein Pathologies in Primary Neuron Cultures and Wild-type Mice 1.00
Contributions of Sound Localization Cues to Azimuth Tuning in the Auditory Midbrain 1.00
Toward Unified Biomarkers for Focal Epilepsy 0.12
Aperiodic activity reflects pathologic waveform shapes in focal epilepsy 0.20
Gene Expression-Based Lesion–Symptom Mapping: FOXP2 and Language Impairments after Stroke 1.00
Neural responses underlying interaural time difference discrimination as a function of sensory reliability in the barn owl 0.86
Disrupted Calcium Dynamics in Reactive Astrocytes Occur with End Feet–Arteriole Decoupling in an Amyloid Mouse Model of Alzheimer's Disease 1.00
PolyQ-Expansion of Ataxin-2 Disrupts Microtubule Stability and Impairs Axon Outgrowth 1.00
Tonic GABA and Glycine Inhibition Control Pain Hypersensitivity via Limiting α2δ-1– and mGluR5–Dependent NMDA Receptor Activity at Primary Afferent→Excitatory Neuron Synapses 1.00
Characterization of Auditory Responsive Neurons in the Mouse Superior Colliculus to White Noise and Frequency-Restricted Sounds 1.00
Spatiotemporal Dynamics of Lateral Na+ Diffusion in Apical Dendrites of Mouse CA1 Pyramidal Neurons 0.29
Presenilin Loss Impairs Synaptic Transmission and Causes Axonal Degeneration through Ryanodine Receptor Dysfunction, Independent of γ-Secretase Activity 1.00
Early Life Injury Alters Spinal Astrocyte Development 1.00
Network Dysfunction Precedes Neurodegeneration in a dox-Regulatable TDP-43 Mouse Model of ALS-FTD 1.00
Perisynaptic Astroglial Response to In Vivo Long-Term Potentiation and Concurrent Long-Term Depression in the Hippocampal Dentate Gyrus 0.83
Cell Type-Specific Alterations in Excitability and Inhibition of Upper Motor Neurons in AlsinKO Mice, a Model of Juvenile Onset ALS 1.00
Retinoid-X-Receptor as a Mediator of Poststroke Recovery by Reversing Age-Associated Phenotypes of Microglia/Hematogenous Macrophages 0.80
Positron Emission Tomography (PET) Neuroimaging of the Pink1-/- Rat Parkinson Disease Model with the Norepinephrine Transporter (NET) Ligand [18F]NS12137 1.00
Salience Signaling and Stimulus Scaling of Ventral Tegmental Area Glutamate Neuron Subtypes 1.00
Microglia Support Both the Singular Form of LTP Expressed by the Lateral Perforant Path and Episodic Memory 1.00
A Positive Allosteric Modulator of the SERCA Pump Rescues Hippocampal Neuronal Circuits Dysfunction and Cognitive Defects in a Mouse Model of Alzheimer's Disease 0.17
ALS mutations shift the isoelectric point of the KIF5A C-terminal inducing protein aggregation and TDP-43 mislocalization 0.04
Transcranial Focused Ultrasound Modulates Feedforward and Feedback Cortico-Thalamo-Cortical Pathways by Selectively Activating Excitatory Neurons 1.00
21 13.97
Psychological stress catalyses free radical–mediated activation of coagulation in humans 0.03
A cascade model of dynamic cerebral autoregulation 0.76
TRIP8bnano peptide prevents cAMP binding to HCN2 channels alleviating pain-like behaviors in rats with neuropathic pain 0.50
Photobiomodulation restores blood–brain barrier integrity after hypoxia via endothelial von Willebrand factor modulation in a humanised tricellular transwell model 0.20
Machine‐learning classification of motor unit types in the adult mouse 0.92
Lactate potentiates NMDA receptor currents via an intracellular redox mechanism targeting GluN2B subunits: implications for synaptic plasticity 0.04
The sympathoregulatory region of the mouse rostral brainstem relies on both GABA and glycine to generate inhibitory currents 1.00
Amyloid β alters vascular CaV1.2 channel spatiotemporal properties 1.00
Profiling muscle mass, function and molecular signalling in females aged 18–80 years and their associations with sex hormones 0.17
Chronic hypoxia impairs L-type Ca2+ channel-mediated myogenic vasoconstriction and cerebral autoregulation in newborn lambs 1.00
Enhancement of hippocampal interneuron excitability by NMDA receptor positive allosteric modulation 1.00
Diet‐induced obesity in mice increases carotid body chemosensitivity via the leptin‐TRPM7 pathway 1.00
Characterization of NTS‐to‐VTA projection neurons reveals higher‐order synaptic organization and distinct responsiveness to cholecystokinin 1.00
Contusive spinal cord injury causes Nav1.8 dysfunction to upregulate small sensory neuron excitability 1.00
Ageing‐induced weakness of mouse NMJs is associated with reduced active zone density, synaptic event kinetics and presynaptic calcium entry 1.00
Ventilatory and cerebrovascular responses to exercise in lowlander children acclimatizing to high‐altitude 0.25
Dual functions of SNAP25 in mouse taste buds 0.05
Selective enhancement of the interneuron network and gamma‐band power via GluN2C/GluN2D NMDA receptor potentiation 1.00
Acute intermittent hypercapnic hypoxia augments left ventricular contractility 0.11
Seizure‐related death exhibits a circadian rhythm independent of seizure timing or sleep in a mouse model of Dravet syndrome 1.00
A polygenetic rat model of divergent aerobic capacity reveals a liver–brain interaction impacting Alzheimer's disease‐like phenotypes 0.95
6 3.95
Femtosecond Soft X-ray Absorption Spectroscopy Identifies Metal-Centered S1 Excited State of Cyanocobalamin 0.21
Electric Double Layer Phenomena Near Surfaces Irreversibly Trigger Assembly of Tau Protein 1.00
Protein Electrostatics Tune the Singlet–Triplet Energy Gap in Natural and Engineered Phototropin Light-Oxygen-Voltage (LOV) Domains 1.00
Protein and Solvent Reorganization Drives Radical Pair Stability in Avian Cryptochrome 4a 0.60
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay 0.14
Mechanism of Giant Magnetic Field Effect in a Red Fluorescent Protein 1.00
7 6.90
Association Between Cholinesterase Inhibitor‐Overactive Bladder Antimuscarinic Prescribing Cascade and Risk of Delirium and Falls Among Individuals Living With Dementia 0.90
Clinician and Informant Report of Neuropsychiatric Symptoms in Dementia 1.00
Characterization of National Institute on Aging‐Funded Clinical Trials for Alzheimer's Disease 1.00
Utilization of Dysphagia Services Among Older Adults Hospitalized With Pneumonia in a Large Sample of scpUS/scp Hospitals 1.00
An Analysis of Institutional Anti‐Amyloid Websites 1.00
Exploring Antipsychotic Initiation Among Persons Living With Dementia in a Comprehensive Dementia Care Program 1.00
Readiness and Barriers to Participate in Alzheimer's and Dementia Research Among Older Adults 1.00
2 1.37
Protection against ferroptosis through maintaining homeostasis of docosahexaenoate-containing phospholipids 0.93
α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation 0.44
17 12.76
IL-15 receptor alpha deficiency triggers depressive-like behaviors via enhanced microglial synapse pruning 0.09
Circuit-targeted modulation of anxiety symptoms in individuals with major depression: A randomized head-to-head TMS trial 1.00
Major depressive disorder shares systemic immune signatures and potential therapeutic targets with inflammatory skin diseases 1.00
A multi-ancestry meta genome-wide association study of migraine among veterans: associations with traumatic brain injury, depression, and post-traumatic stress disorder 1.00
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum 0.65
Dopaminergic tone inhibits spontaneous glutamate release and augments homeostatic synaptic plasticity 1.00
Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls 0.18
Role of LXRβ in oligodendrocytes in neuronal survival 0.75
Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons 1.00
Postmortem tissue biomarkers of menopausal transition 1.00
Predictive value of subgenual cingulate normative connectivity to TMS treatment site for antidepressant response in routine clinical practice: a prospective, multisite cohort study 1.00
Differential effects of lithium on metabolic dysfunctions in astrocytes derived from bipolar disorder patients 0.05
Opposing roles of microglial and macrophagic C3ar1 signaling in stress-induced synaptic and behavioral changes 1.00
Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer’s disease 1.00
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau 0.90
White matter disconnection in acquired criminality 1.00
Reduced glymphatic clearance in early psychosis 0.13
1 0.15
DNA Nanostructures for Modular Growth Factor Delivery and Peripheral Nerve Repair 0.15
28 20.04
Astrocytes connect specific brain regions through plastic networks 0.92
Population-scale repeat expansions elucidate disease risk and brain atrophy 0.98
An enteric neuron ionotropic receptor regulates salt stress resistance 0.77
Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain 1.00
Magnetic resonance control of spin-correlated radical pair dynamics in vivo 1.00
Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease 0.88
Highly dynamic dural sinuses support meningeal immunity 1.00
Astrocytes enable amygdala neural representations supporting memory 0.89
Parkinson’s disease as a somato-cognitive action network disorder 0.26
Intestinal macrophages modulate synucleinopathy along the gut–brain axis 0.07
Ageing promotes microglial accumulation of slow-degrading synaptic proteins 0.79
Quantum spin resonance in engineered proteins for multimodal sensing 0.13
Convergent evolution of scavenger cell development at brain borders 0.09
Mitochondrial transfer from glia to neurons protects against peripheral neuropathy 1.00
Lymphoid gene expression supports neuroprotective microglia function 0.78
A probabilistic histological atlas of the human brain for MRI segmentation 0.26
A parabrachial hub for need-state control of enduring pain 0.91
Repeated head trauma causes neuron loss and inflammation in young athletes 1.00
Alzheimer’s risk allele causes aberrant lipid droplets in microglia 0.98
SLC45A4 is a pain gene encoding a neuronal polyamine transporter 0.15
Microglia–neuron crosstalk via Hex–GM2–MGL2 maintains brain homeostasis 0.05
How short peptides disassemble tau fibrils in Alzheimer’s disease 1.00
Milli-spinner thrombectomy 1.00
Increased CSF drainage by non-invasive manipulation of cervical lymphatics 0.15
The subfornical organ is a nucleus for gut-derived T cells that regulate behaviour 1.00
Astrocyte morphogenesis requires self-recognition 1.00
Closed-loop vagus nerve stimulation aids recovery from spinal cord injury 1.00
Heterogeneous pericoerulear neurons tune arousal and exploratory behaviours 1.00
1 1.00
Clearance of intracranial debris by ultrasound reduces inflammation and improves outcomes in hemorrhagic stroke models 1.00
3 0.52
Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer’s brains 0.13
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance 0.12
Endoplasmic reticulum–mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis 0.27
2 0.33
ALDH2-mediated GABA biosynthesis regulates hippocampal LTP and learning adaptability 0.15
Small-molecule dissolution of stress granules by redox modulation benefits ALS models 0.18
117 71.11
CK2 inhibition suppresses glial inflammation in models of neuroinflammation and neurodegeneration 1.00
Renal coenzyme A (CoA) production from VB5 fuels stem cell proliferation and tumor growth 1.00
Dysfunction of the episodic memory network in the Alzheimer’s disease cascade 0.00
Single-nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy 0.29
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.08
ASO therapy rescues NOTCH2NLC GGC repeat expansion-induced genomic damage, 3D chromatin structural abnormalities, and senescence 0.04
Descending inhibitory rostral ventromedial medulla neurons cause widespread antinociception and contribute to the pain-inhibits-pain phenomenon 0.23
Human narcolepsy is linked to degeneration of both locus coeruleus and hypocretin neurons 1.00
Restoring early postnatal synaptic dysregulation rescues motor neuron degeneration in a mouse model of Spinal and Bulbar Muscular Atrophy 0.08
Ribonuclease 4 Functions in Nociceptor-Mediated Nerve Homeostasis 0.17
DRP1 induces neuroinflammation via transcriptional regulation of NF-ĸB. 1.00
Dopamine and serotonin inversely modulate D2 medium spiny neurons to regulate cocaine reward 1.00
Transcranial focused ultrasound induces source localizable cortical activation in resting state humans when applied concurrently with transcranial electric stimulation 1.00
Behavioral screening defines the molecular Parkinsonism-related subgroups in Drosophila 0.03
Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer’s disease 0.04
Multi-modal dissection of cell-type specific TDP-43 pathology in the motor cortex 0.09
Multimodal evidence for hippocampal engagement and modulation by functional connectivity-guided parietal TMS 1.00
Rapid modulation of choice behavior by ultrasound on the human frontal eye fields 0.06
Sex-specific differences in mediobasal hypothalamus in response to nutritional states 1.00
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects 0.31
Feeding decision-making by a single neuron via disparate neurotransmitters 1.00
A 3D gut-brain-vascular platform for bidirectional crosstalk in gut-neuropathogenesis 0.08
A radiolabeled dendrimer non-invasively identifies and tracks innate immune cell activation in a mouse model of experimental autoimmune encephalomyelitis 1.00
The glymphatic system clears amyloid beta and tau from brain to plasma in humans 1.00
TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism 0.15
Spatial heterogeneity and subtypes of functional connectivity development in youth 0.92
Identification of and NLRP3 inflammasome activation in Alzheimer’s disease retina 0.87
C1q-dependent clearance of alpha-synuclein allows macrophages to transiently limit enteric synucleinopathy in male mice 1.00
Identification of a thermogenic target in the dorsal raphe nucleus for weight management in mice 0.80
Cross-species evidence for a developmental origin of adult hypersomnia with loss of synaptic adhesion molecules 1.00
Application of kilohertz-frequency block to mitigate off-target motor effects of vagus nerve stimulation in swine 1.00
mGluR4–NPDC1 complex mediates α-synuclein fibril-induced neurodegeneration 1.00
Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids 0.04
The Ku80-p53-SIRT1 axis in DNA damage response contributes to sporadic and familial ALS and FTD 0.83
Egr1 is a sex-dependent regulator of neuronal chromatin, structural plasticity, and behaviour 1.00
Human cerebrospinal fluid net flow enhanced by respiration during the awake state 0.93
Identification of a reactive astrocyte subpopulation during HIV-associated pain pathogenesis in mouse models 1.00
C1q drives neural stem cell quiescence by regulating cell cycle and metabolism through BAI1 1.00
Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates 0.87
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology 1.00
Structural pharmacology of SV2A reveals an allosteric modulation mechanism in the major facilitator superfamily 0.88
ZFP612 controls neuropathic pain through epigenetic repression of within the silencer–promoter loop in primary sensory neurons of male mice 0.07
Epigenetic age acceleration, telomere length, and neurocognitive function in long-term survivors of childhood cancer 1.00
Gut mucin fucosylation dictates the entry of botulinum toxin complexes 0.02
Perimenopausal state oestradiol to progesterone imbalance drives Alzheimer’s risk via ERRα dysregulation and energy dyshomeostasis 0.29
Tripotent Lgr5 stem cells in the posterior tongue generate lingual, taste, and salivary gland lineages 0.07
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsy 0.04
Migration of CD8 + TSCM cells into intestine via PPBP–CXCR2 axis increases host stress susceptibility by inhibiting gut microbiome-derived homovanillic acid 0.06
Structural basis of vilazodone dual binding mode to the serotonin transporter 0.25
Optogenetics-integrated gut organ culture system connects enteric neurons dynamics and gut homeostasis 0.09
Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding 0.81
Age modulates the link between stress-related neural activity and mortality 0.02
The Genetic Architecture of the Human Corpus Callosum and its Subregions 0.85
Astrocytes distress triggers brain pathology through induction of δ secretase in a murine model of Alzheimer’s disease 0.10
Sex-specific associations of gene expression with Alzheimer’s disease neuropathology and ante-mortem cognitive performance 0.98
Development of [F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology 0.08
Distinct spatiotemporal patterns of white matter hyperintensity progression 0.14
Thalamocortical hodology to personalize electrical stimulation for focal epilepsy 0.96
Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency 0.59
Fate mapping of peripherally-derived macrophages after traumatic brain injury in mice reveals a long-lasting population with a distinct transcriptomic signature 1.00
A doubly stochastic renewal framework for partitioning spiking variability 1.00
Brain–cervical lymph node crosstalk contributes to brain injury induced by subarachnoid hemorrhage in mice 0.07
Gustatory thalamic neurons mediate aversive behaviors 1.00
Aging in mice alters regionally enriched striatal astrocytes 1.00
Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids 0.25
Targeting prostaglandin E2 receptor 2 in Schwann cells inhibits inflammatory pain but not inflammation 0.28
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease 0.51
Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model 0.06
CSF total tau as a proxy of synaptic degeneration 0.71
Distinct manifestations of excitatory-inhibitory imbalance associated with amyloid-β and tau in patients with Alzheimer’s disease 1.00
Integrating artificial intelligence and optogenetics for Parkinson’s disease diagnosis and therapeutics in male mice 0.19
Prefrontal cortex astrocytes modulate distinct neuronal populations to control anxiety-like behavior 0.88
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial 0.79
Astrocyte priming enhances microglial Aβ clearance and is compromised by APOE4 0.07
Regional heterogeneity of the blood-brain barrier 0.78
Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats 0.85
14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state 1.00
SERBP1-PCIF1 complex-controlled m6Am modification in glutamatergic neurons of the primary somatosensory cortex is required for neuropathic pain in mice 0.06
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification 0.23
Sleep drive, not total sleep amount, increases seizure risk 1.00
Early intervention with electrical stimulation reduces neural damage after stroke in non-human primates 1.00
A human brain network linked to restoration of consciousness after deep brain stimulation 0.80
Somatostatin-expressing interneurons induce early NO-driven and late specific astrocyte-mediated vasodilation 0.17
AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer’s Disease clinical trial 0.29
Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice 0.09
Intraoperative nerve-specific fluorescence visualization in head and neck surgery: a Phase 1 trial 1.00
A multicenter longitudinal study of cholinergic subgroups in Parkinson disease 0.77
Boundary complexity of cortical and subcortical areas predicts deep brain stimulation outcomes in Parkinson’s disease 1.00
Microglial cyclooxygenase-1 modulates cerebral capillary basal tone in vivo in mice 0.85
Flavoproteins as native and genetically encoded spin probes for ESR spectroscopy 1.00
Memantine inhibits calcium-permeable AMPA receptors 0.71
Noncanonical short-latency auditory pathway directly activates deep cortical layers 1.00
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain 0.34
HDL-bound S1P affects the subventricular niche and early neuropathological features of Alzheimer’s disease 0.05
Brain-wide input-output analysis of tuberal nucleus somatostatin neurons reveals hierarchical circuits for orchestrating feeding behavior 0.07
FABP7 is increased in progressive multiple sclerosis and induces a pro-inflammatory phenotype in monocytes through a glycolytic switch 1.00
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease 0.48
Variable and interactive effects of Sex, APOE ε4 and TREM2 on the deposition of tau in entorhinal and neocortical regions 0.92
AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice 1.00
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation 0.05
Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis 0.49
Refining centromedian nucleus stimulation for generalized epilepsy with targeting and mechanistic insights from intraoperative electrophysiology 1.00
Mechanism of human α3β GlyR regulation by intracellular M3/M4 loop phosphorylation and 2,6-di-tert-butylphenol interaction 1.00
Pharmacological and physiological activation of TGR5 in the NTS lowers food intake by enhancing leptin-STAT3 signaling 0.22
Convergent mapping of a tremor treatment network 0.22
Glioma-neuronal circuit remodeling induces regional immunosuppression 0.98
An integrative systems-biology approach defines mechanisms of Alzheimer’s disease neurodegeneration 1.00
Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain 0.19
Gabapentinoids confer survival benefit in human glioblastoma 0.96
Energy state guides reward seeking via an extended amygdala to lateral hypothalamus pathway 1.00
Control of spatiotemporal activation of organ-specific fibers in the swine vagus nerve by intermittent interferential current stimulation 0.59
A minimally invasive thrombotic model to study stroke in awake mice 1.00
Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology 1.00
Astrocytic GLUT1 deletion in adult mice enhances glucose metabolism and resilience to stroke 0.06
Nageotte nodules in human dorsal root ganglia reveal neurodegeneration in diabetic peripheral neuropathy 0.93
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier 1.00
Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy 1.00
4 2.60
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration 0.89
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.12
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington’s disease highlight shared and tissue-specific effects 0.71
Base editing of trinucleotide repeats that cause Huntington’s disease and Friedreich’s ataxia reduces somatic repeat expansions in patient cells and in mice 0.88
4 3.09
A spatially coordinated keratinocyte–fibroblast circuit recruits MMP9⁺ myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity 1.00
A transcriptomic microglia taxonomy across mouse and human pathologies 0.18
Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases 0.92
Spatial proteomics of Alzheimer’s disease-specific human microglial states 0.98
17 10.72
Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals 0.30
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration 0.28
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial 0.75
The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial 0.95
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial 0.84
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial 0.90
Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial 0.44
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial 0.99
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.33
Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial 0.22
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis 0.96
Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial 0.21
AI-driven reclassification of multiple sclerosis progression 0.15
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis 0.79
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases 0.67
Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging 1.00
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial 0.95
35 25.07
Laminar organization of cellular microcircuits modulating human interictal epileptiform discharges 1.00
Brain motion is driven by mechanical coupling with the abdomen 0.96
Early dopamine disruption in the entorhinal cortex of a knock-in model of Alzheimer’s disease 0.87
White matter pathways mediating dorsolateral prefrontal TMS therapy for depression 0.40
UBQLN2 links proteotoxicity with lipid metabolism in neurodegeneration 1.00
Adversarial AI reveals mechanisms and treatments for disorders of consciousness 0.66
Circuit response to neuromodulation characterized with simultaneous deep brain stimulation and precision neuroimaging in humans 0.05
Magnetic resonance microscopy maps widespread effects of Alzheimer’s disease on brain structures and behavior in mice 0.95
Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos 1.00
Base barrier cells provide compartmentalization of choroid plexus, brain and CSF 0.23
Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins 0.89
Sleep-dependent infraslow rhythms are evolutionarily conserved across reptiles and mammals 0.09
Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons 0.91
A fully iPS-cell-derived 3D model of the human blood–brain barrier for exploring neurovascular disease mechanisms and therapeutic interventions 0.02
Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling 0.25
Astrocytic Sox9 overexpression in Alzheimer’s disease mouse models promotes Aβ plaque phagocytosis and preserves cognitive function 1.00
Estrogen modulates reward prediction errors and reinforcement learning 1.00
Subsecond dopamine fluctuations do not specify the vigor of ongoing actions 0.83
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease 0.38
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD 0.73
Differential synaptic depression mediates the therapeutic effect of deep brain stimulation 0.88
Region-specific drivers of CSF mobility measured with MRI in humans 0.08
Astrocytic Ca2+ prevents synaptic depotentiation by limiting repetitive activity in dendrites during motor learning 0.50
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals 0.27
Embryonic motor neuron programming factors reactivate immature gene expression and suppress ALS pathologies in postnatal motor neurons 1.00
Impaired capillary–venous drainage contributes to gliosis and demyelination in mouse white matter during aging 0.92
Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson’s disease 1.00
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.36
Closed-loop electrical stimulation prevents focal epilepsy progression and long-term memory impairment 0.92
Heat shock proteins function as signaling molecules to mediate neuron–glia communication in C. elegans during aging 1.00
Protective exercise responses in the dentate gyrus of Alzheimer’s disease mouse model revealed with single-nucleus RNA-sequencing 1.00
A route for cerebrospinal fluid flow through leptomeningeal arterial–venous overlaps enables macromolecule and fluid shunting 0.92
Neuronal aging causes mislocalization of splicing proteins and unchecked cellular stress 1.00
Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development 1.00
Lemborexant ameliorates tau-mediated sleep loss and neurodegeneration in males in a mouse model of tauopathy 1.00
3 1.45
Midkine attenuates amyloid-β fibril assembly and plaque formation 1.00
Structural analyses define the molecular basis of clusterin chaperone function 0.14
Distinct tau filament folds in human MAPT mutants P301L and P301Tc 0.31
30 24.81
Astrocyte cell volume dynamics across cortical states and transitions 0.19
Tau seeds induce neurofibrillary tangle formation across brain regions via individual-specific connectivity 1.00
Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remodeling and neurogenesis in developing thalamic circuitry 1.00
Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models 1.00
Temporal regulation of human reactive astrocytes reveals their capacity for antigen presentation 1.00
Enhancers that direct gene expression to central nervous system vascular endothelial cells in vivo 1.00
Synthetic serum markers enable noninvasive monitoring of gene expression in primate brains 1.00
Astrocyte-microglia crosstalk through Hevin and Toll-like receptor signaling controls developmental thalamocortical synapse refinement 1.00
Developmental reprogramming in melanocortin neurons modulates diet-induced obesity in mice 1.00
A dorsal hippocampus-prodynorphinergic dorsolateral septum-to-lateral hypothalamus circuit mediates contextual gating of feeding 1.00
Hippocampal estrogen levels, receptor types, and epigenetics contribute to sex-specific memory vulnerabilities to concurrent acute stresses 0.83
The Alzheimer’s disease risk genes MS4A4A and MS4A6A cooperate to negatively regulate TREM2 and microglia states 0.86
TDP-43 dysfunction compromises UPF1-dependent mRNA metabolism in ALS 1.00
Hypertension-induced neurovascular and cognitive dysfunction at single-cell resolution 1.00
The brain neurovascular epigenome and its association with dementia 0.20
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer’s disease by impairing microglial function 1.00
Regionally mapped astrocytic responses to cortical and white matter stroke show differential roles in astrocyte-induced vascular remodeling 1.00
Restoration of temporal separability between beta and movement ensemble co-firing with motor recovery 1.00
Segregated supramammillary-dentate gyrus circuits modulate cognitive and affective function in healthy and Alzheimer’s disease model mice 0.48
Microglia regulate neuronal activity via structural remodeling of astrocytes 0.06
Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain 1.00
G-protein-coupled receptor ADGRG1 drives a protective microglial state in Alzheimer's disease through MYC activation 1.00
In vivo 7 Tesla MRI of non-human primate intracortical microvascular architecture 0.08
GADD45G operates as a pathological sensor orchestrating reactive gliosis and neurodegeneration 1.00
Encoding the glucose identity by discrete hypothalamic neurons via the gut-brain axis 0.14
Major-depressive-disorder-associated dysregulation of ZBTB7A in orbitofrontal cortex promotes astrocyte-mediated stress susceptibility 1.00
The cell-surface shared proteome of astrocytes and neurons and the molecular foundations of their multicellular interactions 1.00
Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics 1.00
Specific targeting of brain endothelial cells using enhancer AAV vectors 1.00
Distinct systemic impacts of Aβ42 and Tau revealed by whole-organism snRNA-seq 0.96
1 1.00
Peripapillary hyperreflective ovoid mass-like structures before and after intracranial decompression: a longitudinal cohort study 1.00
6 1.38
Five energy metabolism pathways show distinct regional distributions and lifespan trajectories in the human brain 0.20
Sleep deprivation and sleep intensity exert distinct effects on cerebral vasomotion and brain pulsations driven by the respiratory and cardiac cycles 0.03
Oxytocin neurons drive melanocortin circuit maturation via vesicle release during a neonatal critical period 0.13
Identification and characterization of tumor-associated astrocyte subpopulations and their interactions with the tumor microenvironment in experimental glioblastomas 0.09
Seizure evolution in a mouse model of West syndrome involves complex and time-dependent synapse remodeling, gliosis and alterations in lipid metabolism 0.01
Neuron-specific Agrin splicing by Nova RNA-binding proteins regulates conserved neuromuscular junction development in chordates 0.93
2 2.00
A scaffold attachment factor PHM-2 regulates synaptic transmission through SLO-2 potassium channel in C. elegans 1.00
The Drosophila G protein-coupled receptor, GulpR, is essential for lipid mobilization in response to nutrient-limitation 1.00
2 0.17
Re-evaluating malarial retinopathy to improve its diagnostic accuracy in paediatric cerebral malaria: A retrospective study 0.11
Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson’s disease: A Chinese retrospective multicenter cohort study 0.06
1 1.00
Boundary-Driven Delayed-Feedback Control of Spatiotemporal Dynamics in Excitable Media 1.00
60 47.18
Quantitative assessment of flow between cerebrospinal and interstitial fluid compartments in humans 0.02
Failure of early B cell tolerance and possible BCR signaling dysregulation underlie NF155-mediated autoimmune nodopathies 0.75
Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability 0.11
Distinct laminar origins of sensory-evoked high-gamma and low-frequency ECoG signals revealed by optogenetics 1.00
Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy 0.98
Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system 0.81
Inorganic phosphate and the rapid mobilization of metabolic energy in neurons 1.00
Sleep alters neurovascular and hydrodynamic coupling in the human brain 0.05
High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin 0.11
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study 0.47
Macrophage–glia interactions regulate immune damage to enteric neurons during West Nile virus infection 1.00
SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study 0.43
Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion 1.00
RNA-binding activity of PHGDH drives amyloid-beta production in a human brain organoid model of sporadic Alzheimer’s disease 1.00
Gustatory avoidance of fatty acids by Aedes aegypti depends on an arthropod-specific TRP channel 1.00
GABA corelease guides the functional maturation of glycinergic synapses in an auditory sound localization circuit 1.00
Olfactory inputs to appetite neurons in the hypothalamus 1.00
Microvascular architecture and physiological fluctuations constrain the control of cerebral microcirculation 0.40
Highly sensitive chemiluminescence imaging of misfolded proteins in neurodegenerative models 0.87
Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection 1.00
Peripheral nerve injury reduces macrophage efferocytosis to facilitate neuropathic pain 1.00
PIP2 corrects an endothelial Piezo1 channelopathy 1.00
Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury 0.55
Hormonal mechanisms of women’s risk in the face of traumatic stress 1.00
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility 1.00
Mapping epileptogenic brain using a unified spatial–temporal–spectral source imaging framework 1.00
Neuromodulatory control of energy reserves in dopaminergic neurons 1.00
Neurofluid circulation changes during a focused attention style of mindfulness meditation 1.00
Erasable serum markers 1.00
Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress–induced cytotoxicity 0.95
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology 0.88
Full interhemispheric integration sustained by a fraction of posterior callosal fibers 0.50
Parkinsonism disrupts the balance between excitatory and inhibitory activity within the primary motor cortex during movement 1.00
Dynamic control of NMDA receptor Ca2+ permeability by endogenous and synthetic modulators 1.00
Activity-dependent citrate dynamics in neurons 1.00
Geometrical compartmentalization of trigger waves 0.80
Nav1.8: Intrinsic limits on the functional effect of abrogation in DRG neurons 1.00
Biomarkers of immune dysregulation and posttreatment inflammation in spinal muscular atrophy 1.00
Endothelial αvβ3 integrin induction during hypoxia protects blood–brain barrier integrity 1.00
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A) 0.44
Dural ectopic lymphatic structures accumulate during aging and exhibit dysregulation in neurodegenerative diseases 0.07
Immune-responsive gene 1: The mitochondrial key to Th17 cell pathogenicity in CNS autoimmunity 0.92
Actions of the antiseizure drug carbamazepine in the thalamic reticular nucleus: Potential mechanism of aggravating absence seizures 1.00
Targeting PBK with small-molecule 1-O-acetyl-4R,6S-britannilactone for the treatment of neuroinflammation 0.22
Glycogen supports glycolytic plasticity in neurons 1.00
Thalamic CGRP neurons define a spinothalamic pathway for affective pain 0.94
Regulation of Na/Ca exchange by cytoplasmic protons modifies intracellular calcium dynamics and the cardiac response to ischemia 1.00
Vamp3/syntaxin 4 mediates the basolateral membrane fusion of TfR transcytosis across the BBB and is exploited by pathogenic Escherichia coli 0.33
Cerebral blood flow is modulated by astrocytic cAMP elevation independently of IP3R2-mediated Ca2+ signaling in mice 0.09
Fluid dynamics model of the cerebral ventricular system 0.50
Decreased mitochondrial activity in the demyelinating cerebellum of progressive multiple sclerosis and chronic EAE contributes to Purkinje cell loss 1.00
Keratinocyte–TRPV1 sensory neuron interactions in a genetically controllable mouse model of chronic neuropathic itch 0.92
Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine 1.00
Neuron–astrocyte associative memory 1.00
Inhibiting 15-PGDH blocks blood–brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury 0.97
Stathmin-2 enhances motor axon regeneration after injury independent of its binding to tubulin 0.75
Inflammatory cytokine upd3 induces axon length–dependent synapse removal by glia 0.67
Loss of insulin signaling in microglia impairs cellular uptake of Aβ and neuroinflammatory response exacerbating AD-like neuropathology 0.75
Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2 activation in a model of MS and CNP 0.91
Cortical signatures linked to behavior quantitatively track arousal levels 1.00
9 6.38
Endovascular versus Medical Management of Basilar Artery Occlusion Strokes in Patients with Low Stroke Severity. 1.00
Brain MRI Analysis of Cumulative Blast Exposure and Intracranial Aneurysms in Special Operations Forces. 0.82
Dynamic MRI of Fluid and Solute Transportation across the Arachnoid Barrier in the Human Meninges. 1.00
Endovascular Therapy versus Medical Management for Basilar Artery Occlusion Presenting beyond 24 Hours. 0.21
Statins Reduce Wall Enhancement at Vessel Wall MRI in Unruptured Vertebrobasilar Dissecting Aneurysms: A Randomized Controlled Trial. 0.14
Endovascular Thrombectomy versus Standard Medical Management in Treatment of Acute Medium Vessel Occlusion Strokes: A Multicenter Registry. 0.25
Quantification of Perivascular Flow Dynamics of Human Cerebrospinal Fluid Along Major Arteries Using Phase-Contrast MRI. 1.00
Susceptibility MRI Helps Predict Mild Cognitive Impairment Onset and Cognitive Decline in Cognitively Unimpaired Older Adults. 1.00
Quantitative Ultrashort Echo Time MRI for Evaluation of Sciatic Nerve Degeneration and Regeneration in Rat Models. 0.96
8 6.44
Luminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators 0.90
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.86
Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration 0.05
Discrete spatiotemporal encoding of striatal dopamine transmission 1.00
GPR45 modulates Gαs at primary cilia of the paraventricular hypothalamus to control food intake 0.90
GPCR signaling gates astrocyte responsiveness to neurotransmitters and control of neuronal activity 1.00
Norepinephrine changes behavioral state through astroglial purinergic signaling 0.73
Norepinephrine signals through astrocytes to modulate synapses 1.00
41 28.36
Directional guidance to orient Schwann cell alignment in nerve regeneration requires Plexin-B1 0.80
Broad presence of ferromagnetism in bees and relationship to phylogeny, natural history, and sociality 0.80
Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injury 1.00
Enteric botulinum neurotoxins facilitate infection by Salmonella and Shigella 0.08
Structural basis for domain coupling in heteromeric glycine receptors revealed by an atypical allosteric agonist 0.50
Tubulin polymerization dynamics are influenced by magnetic isotope effects consistent with the radical pair mechanism 0.20
α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction 1.00
Neuronal GPR75 deficiency protects against diet-induced obesity in a humanized mouse model 0.96
Cryo-EM of autoantibody-bound NMDA receptors reveals antigenic hotspots in an active immunization model of anti-NMDAR encephalitis 1.00
GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis 0.10
Brainstem circuit for sickness-induced sleep 0.88
State-dependent modulation of spiny projection neurons controls levodopa-induced dyskinesia in a mouse model of Parkinson’s disease 1.00
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology 0.62
Identification and characterization of botulinum neurotoxin–like two-component toxins in Paeniclostridium ghonii 0.61
Adhesive nonfibrotic bioelectronic interfaces on diverse peripheral nerves for long-term functional neuromodulation 1.00
Dopamine and serotonin cotransmission filters striatonigral synaptic activity via 5-HT1B receptor activation 0.33
Calcium-based synaptic and structural plasticity link pathological activity to synaptic reorganization in Parkinson’s disease 0.63
DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease 0.29
Preventing neuropathy and improving anticancer chemotherapy with a carbazole-based compound 0.08
The chloride intracellular channel 1 (CLIC1) is essential for microglial morphodynamics and neuroinflammation 0.07
Vasa vasorum plexus formation in intracranial aneurysm associates with microcalcification and wall thickening 1.00
Cryo-EM snapshots of NMDA receptor activation illuminate sequential rearrangements 1.00
Differential modulation of movement speed with state-dependent deep brain stimulation in Parkinson’s disease 0.12
A nut-and-bolt assembly of the bimodular large progenitor botulinum neurotoxin complex 0.50
Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits 0.08
Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels 0.97
Cholinergic regulation of osteocyte mechanobiology: A paradigm for bone adaptation 1.00
Delivery of a fibrin-binding hemostatic polymer ameliorates neurovascular damage and neural tissue loss after traumatic brain injury 1.00
G proteins of the G12 family expressed by POMC neurons regulate key metabolic functions 0.93
SARS-CoV-2 induces Alzheimer’s disease–related amyloid-β pathology in ex vivo human retinal explants and retinal organoids 1.00
Perineural immune environment of olfactory nerves is reshaped by neuroinflammatory drainage and connects to ethmoid bone marrow 1.00
Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 0.48
Inhibition of acute lung inflammation by a neuroimmune circuit induced by vagal nerve stimulation 1.00
Reduced DJ-1-F1Fo ATP synthase association correlates with midbrain dopaminergic neuron vulnerability in idiopathic Parkinson’s disease 0.14
Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration 0.87
Coding principles of dopaminergic transmission modes 1.00
Optimal focused ultrasound lesion location in essential tremor 0.67
Niemann Pick C1 mistargeting disrupts lysosomal cholesterol homeostasis contributing to neurodegeneration in a Batten disease model 1.00
Characterizing the expression profile of 3R tau pathology in Pick’s disease 1.00
A neuroimmune pathway drives bacterial infection 0.67
Supervised and unsupervised learning reveal heroin-induced impairments in astrocyte structural plasticity 1.00
18 13.30
Autophagosome-targeting single-domain antibody clears tau in patient-derived neurons and improves motor function in tauopathy mice 1.00
Foldamers rescue synucleinopathy phenotypes in multiple in vitro and in vivo models 0.70
Engineered zinc finger repressors induce a prolonged and selective repression of SCN9A in nociceptors of nonhuman primates 1.00
Selective targeting of mutant huntingtin intron 1 improves rescue provided by antisense oligonucleotides in Huntington’s disease mice 0.50
Lowering the HTT1a transcript as an effective therapy for Huntington’s disease in a knockin mouse model 0.38
Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer’s disease models 0.76
Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsy 0.04
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis 0.06
An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain–related behaviors in humanized mice 1.00
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer’s disease 0.88
Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy 0.97
LRRC8A constitutively inhibits pain hypersensitivity in rodent models by restraining NMDA receptor activity at spinal cord synapses 1.00
Deletion of the X-chromosomal gene Kdm6a in microglia of female mice ameliorates neuroinflammation and restores translatome profiles 1.00
Deletion of murine Sarm1 results in a microenvironment that delays peripheral nerve regeneration after injury 1.00
Hippocampal spreading depolarization as a driver of postictal ambulation 0.05
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21–FOXO1 axis in pathogenic T helper 17 cells 0.98
Bezafibrate improves mitochondrial function, blood-brain barrier integrity, and social deficits in models of 22q11.2 deletion syndrome 1.00
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy 0.98
1 1.00
Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study 1.00
2 0.11
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 0.07
Amyloid-β disrupts APP-regulated protein aggregation and dissociation from recycling endosomal membranes. 0.04
2 1.14
A Charge-Reversal Point Mutation Completely Depletes Flavin Chromophore from European Robin Cryptochrome 4a Protein 0.14
Spin-Correlated Radical Pairs as Magnetic Switches for Controlling Emissive Triplet States via Triplet–Triplet Energy Transfer 1.00
5 1.63
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials 0.39
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial 0.04
Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort study 0.94
Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferiority trial 0.25
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial 0.01
7 4.47
Door-in-door-out times and outcomes in patients with acute ischaemic stroke transferred for endovascular therapy in the USA: a retrospective cohort study 1.00
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1 Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial 0.50
Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case–control study 0.98
Sleep EEG and respiratory biomarkers of sudden unexpected death in epilepsy (SUDEP): a case–control study 0.95
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.36
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial 0.56
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study 0.11
1 0.34
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis 0.34
9 4.29
Asundexian for Secondary Stroke Prevention 0.07
Zorevunersen in Children and Adolescents with Dravet Syndrome 0.82
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1 1.00
Fremanezumab in Children and Adolescents with Episodic Migraine 0.55
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus 0.80
Risdiplam in Presymptomatic Spinal Muscular Atrophy 0.18
Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke 0.08
Intravenous Tenecteplase before Thrombectomy in Stroke 0.06
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 0.73

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.